Insider Transactions in Q1 2022 at Athira Pharma, Inc. (ATHA)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 31
2022
|
Kelly A Romano |
BUY
Open market or private purchase
|
Direct |
8,000
+49.03%
|
$104,000
$13.11 P/Share
|
Feb 18
2022
|
Kevin Church CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,152
+6.21%
|
$3,152
$1.19 P/Share
|
Jan 04
2022
|
Glenna Mileson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,305
+6.1%
|
$6,305
$1.35 P/Share
|